SCHEMBL7960759

SCHEMBL7960759

Cc1ccc2c(c1)NC(=O)C(NC(=O)OC(C)(C)C)CN2C(=O)C1CCCCC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
EPHX2 P34913 2/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX15 P16050 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
SMYD3 Q9H7B4 1/20 0.34
LMNA P02545 1/20 0.33
BTK Q06187 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177881 0.99 GAA (0.38) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL6176160 0.87 IDH1 (0.45) GAAEPHX2TSHRKMT2AKDM4E
SCHEMBL7950687 0.87 GAA (0.40) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL6176303 0.86 GAA (0.40) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL6178399 0.86 EPHX2 (0.43) GAAEPHX2KMT2AKDM4EALDH1A1
SCHEMBL6175862 0.86 HSD17B10 (0.40) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL7950958 0.86 HSD17B10 (0.40) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL7950643 0.84 GAA (0.38) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL6179125 0.84 EPHX2 (0.39) GAAEPHX2TSHRHSD17B10ALOX15
SCHEMBL7950813 0.83 GAA (0.37) GAAEPHX2TSHRHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed